Exact Mass: 429.19
Exact Mass Matches: 429.19
Found 120 metabolites which its exact mass value is equals to given mass value 429.19
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7-Benzylidenenaltrexone
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
Abiraterone sulfate
Abiraterone sulfate is a metabolite of abiraterone. Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) (prostate cancer not responding to androgen deprivation or treatment with antiandrogens). It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. (Wikipedia)
7-Benzylidenenaltrexone
2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid
8-Benzylcanadine
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.163 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.170
Ala Asp Pro Gln
Ala Asp Gln Pro
Ala Glu Asn Pro
Ala Glu Pro Asn
Ala Asn Glu Pro
Ala Asn Pro Glu
Ala Pro Asp Gln
Ala Pro Glu Asn
Ala Pro Asn Glu
Ala Pro Gln Asp
Ala Gln Asp Pro
Ala Gln Pro Asp
Asp Ala Pro Gln
Asp Ala Gln Pro
Asp Pro Ala Gln
Asp Pro Gln Ala
Asp Gln Ala Pro
Asp Gln Pro Ala
Glu Ala Asn Pro
Glu Ala Pro Asn
Glu Gly Pro Gln
Glu Gly Gln Pro
Glu Asn Ala Pro
Glu Asn Pro Ala
Glu Pro Ala Asn
Glu Pro Gly Gln
Glu Pro Asn Ala
Glu Pro Gln Gly
Glu Gln Gly Pro
Glu Gln Pro Gly
Gly Glu Pro Gln
Gly Glu Gln Pro
Gly Pro Glu Gln
Gly Pro Gln Glu
Gly Gln Glu Pro
Gly Gln Pro Glu
Asn Ala Glu Pro
Asn Ala Pro Glu
Asn Glu Ala Pro
Asn Glu Pro Ala
Asn Pro Ala Glu
Asn Pro Glu Ala
Pro Ala Asp Gln
Pro Ala Glu Asn
Pro Ala Asn Glu
Pro Ala Gln Asp
Pro Asp Ala Gln
Pro Asp Gln Ala
Pro Glu Ala Asn
Pro Glu Gly Gln
Pro Glu Asn Ala
Pro Glu Gln Gly
Pro Gly Glu Gln
Pro Gly Gln Glu
Pro Asn Ala Glu
Pro Asn Glu Ala
Pro Gln Ala Asp
Pro Gln Asp Ala
Pro Gln Glu Gly
Pro Gln Gly Glu
Gln Ala Asp Pro
Gln Ala Pro Asp
Gln Asp Ala Pro
Gln Asp Pro Ala
Gln Glu Gly Pro
Gln Glu Pro Gly
Gln Gly Glu Pro
Gln Gly Pro Glu
Gln Pro Ala Asp
Gln Pro Asp Ala
Gln Pro Glu Gly
Gln Pro Gly Glu
(S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-(4-ISOPROPYL-PHENYL)-PROPIONIC ACID
4-[BUTYL([2-(1H-TETRAZOL-5-YL)[1,1-BIPHENYL]-4-YL]METHYL)AMINO]-5-PYRIMIDINECARBOXYLIC ACID
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methylphenyl)-N-(3-pyridinylmethyl)- (9CI)
17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochlori de dihydrate
6-[2-Oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-(phenylmethyl)-7-triazolo[4,5-d]pyrimidinone
(6E)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5alpha)-
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
N-[3-chloro-4-[4-[oxo-(4-propoxyphenyl)methyl]-1-piperazinyl]phenyl]propanamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(4-morpholinyl)phenyl]-3-imidazo[1,2-a]pyrazinamine
(4As,6Z,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
(1R,9S,10S,11S)-N-cyclobutyl-12-[(2,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-N-cyclobutyl-12-[(2,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulate
4F 4PP (oxalate)
4F 4PP (oxalate) is a selective 5-HT2A antagonist with almost as high affinity (Ki= 5.3 nM) as ketanserin but with a much lower affinity for 5-HT2C sites (Ki= 620 nM)[1][2][3][4].
GNE-9278
GNE-9278 is a highly selective positive allosteric modulator of NMDAR that acts at the GluN1 transmembrane domain (TMD). GNE-9278 acts on activated NMDARs to increase peak current and agonist affinity[1].